Your shopping cart is currently empty

NPH16 is an orally active PD-1/PD-L1 inhibitor with an IC50 of 2.24 nM. It promotes apoptosis in HepG2 cells and demonstrates outstanding antitumor efficacy and favorable pharmacokinetic properties in vivo. NPH16 is applicable for liver cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NPH16 is an orally active PD-1/PD-L1 inhibitor with an IC50 of 2.24 nM. It promotes apoptosis in HepG2 cells and demonstrates outstanding antitumor efficacy and favorable pharmacokinetic properties in vivo. NPH16 is applicable for liver cancer research. |
| In vitro | NPH16 exhibits dose-dependent cytotoxicity against HepG2 cells within a co-culture system at concentrations ranging from 0-2 μM over a 48-hour period. Additionally, NPH16 interacts with human PD-L1 (dissociation constant K D = 54.6 nM) and mouse PD-L1 (dissociation constant K D = 51.6 nM) in a concentration-dependent manner at concentrations between 0.02-20 μM over a duration of 0-700 seconds. |
| In vivo | In a C57BL/6 mouse model bearing HEPA1-6 liver cancer tumors, NPH16 (50-100 mg/kg, p.o., 7 days) demonstrated significant dose-dependent antitumor activity throughout the treatment period. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.